Open-label, Single -Center, Prospective Study on the Efficacy and Safety of Intracanalicular Dexamethasone Insert 0.4mg (Dextenza) in the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery - The ADHERE Study
Latest Information Update: 19 Jun 2023
Price :
$35 *
At a glance
- Drugs Dexamethasone (Primary) ; Gemcitabine; Prednisolone acetate
- Indications Ocular inflammation; Ocular pain; Postoperative inflammation; Postoperative pain
- Focus Therapeutic Use
- Acronyms The ADHERE Study
- 14 Jun 2023 Status changed from recruiting to completed.
- 10 Jul 2020 New trial record